The groundbreaking therapy of the medication represents a major development in the care of type 2 diabetes. Unlike existing drugs, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatide-peptide157233.articlesblogger.com/64431278/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment